The US Food and Drug Administration (FDA) on Friday proposed to reclassify non-invasive bone growth stimulators under two product codes from class III to class II, allowing the devices to be marketed ...

Orthofix Medical (NASDAQ:OFIX) reported second-quarter results that management said reflected improving operating trends ...

Shares of Orthofix Medical (OFIX) lost ~8% in the premarket on Thursday after the orthopedic device maker cut its full-year outlook, citing certain changes to Medicare reimbursements applicable to its ...

Orthofix Medical Inc. (NASDAQ:OFIX) draws attention after a Medicare coverage reversal on bone growth stimulators reshapes ...

Please provide your email address to receive an email when new articles are posted on . Xstim Inc. received FDA premarket application approval of its Xstim spine fusion stimulator. The device is ...

obstruction of a June 2008 federal audit; charges were recorded in Q1 2011 * Says this final settlement also includes the resolution of a related qui tam category S&P 500 ekes out all-time closing ...